ROTHSCHILD HOUSE GROUP
CHAPEL STREET, TRING
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 17 | 18 | 94.4% | |
| HF 4 | 2011 | 12 | 16 | 75.0% | |
| HF 4 | 2012 | 17 | 21 | 81.0% | |
| HF 4 | 2013 | 12 | 15 | 80.0% | |
| HF004 | 2014 | 6 | 6 | 100.0% | |
| HF004 | 2015 | 13 | 14 | 92.9% | |
| HF004 | 2016 | 32 | 33 | 97.0% | |
| HF004 | 2017 | 49 | 49 | 100.0% | |
| HF004 | 2018 | 53 | 59 | 89.8% | |
| HF004 | 2019 | 56 | 60 | 93.3% | |
| HF004 | 2020 | 47 | 51 | 92.2% | |
| HF006 | 2021 | 79 | 81 | 97.5% | |
| HF006 | 2022 | 110 | 117 | 94.0% | |
| HF006 | 2023 | 115 | 125 | 92.0% |
